Top image

Our Partners

We are privileged to work with some amazing organisations in the field of translational cancer research. 




Thanks to their membership, Sydney Catalyst covers the full pathway from basic research through to clinical trials and clinical practice, extending to population, psychosocial and health economics research.

Collectively our group has combined research income, publication records and leading researchers on a scale and quality equivalent to international cancer centres and with excellent international links in basic sciences and clinical trials.

We invite you to read about our member groups and their specialties below.

  • ANZAC Research Institute
    ANZAC Research Institute

    Group Lead: Prof. David Handelsman.

    ANZAC RI's mission is to provide leadership and excellence in health and medical research activities throughout Australia, with a focus on aging, to improve the future health and medical care for the Australasian community.  


    Dendritic Cell Research (DCR) led by Professor Derek Hart.

  • Asbestos Disease Research Institute
    Asbestos Disease Research Institute

    Group Lead: Dr. Ken Takahashi

    ADRI was established by the Asbestos Diseases Research Foundation (ADRF), a charitable, not-for-profit foundation dedicated to assist and support the research efforts of ADRI into asbestos-related diseases.

    Supporting ADRI's research can be done in a number of ways. For details visit the ADRI Support page.

  • Bathurst Base Hospital
    Bathurst Base Hospital

    Group Lead: Ruth Jones

    A part of the Western NSW Local Health District.

  • Centenary Institute
    Centenary Institute

    Group Lead: Prof. Mathew Vadas

    The Centenary Institute is a world-leading independent Medical Research Institute. Their strength is in uncovering disease mechanisms and applying this knowledge to improve diagnostics and treatments for patients and find cures for some of the most chronic diseases affecting today's society.

    If you would like to make a donation that will help scientists advance their research in finding better treatment options and saving lives visit Centenary's support page.

  • Chris O'Brien Lifehouse
    Chris O'Brien Lifehouse

    Group Lead: Prof. Michael Boyer

    The mission at Chris O'Brien Lifehouse is to improve the quality of life of cancer patients, carers and their families by advancing the understanding, diagnosis, treatment, cure and prevention of the disease.

    If you would like to help Chris O'Brien Lifehouse achieve their vision to transform cancer treatment visit their support page for more information.

  • Concord Cancer Centre, Concord Repatriation General Hospital
    Concord Cancer Centre, Concord Repatriation General Hospital

    Group Lead: Assoc. Prof. Philip Beale

    Concord Cancer Centre provides first class cancer treatment and is a research leader in a number of cancer related areas. Concord Cancer Centre is based at Concord Repatriation General Hospital, a major tertiary hospital in Sydney Local Health District.

  • Dubbo Hospital
    Dubbo Hospital

    Group Lead: Ruth Jones

    A service of the Western NSW Local Health District.

  • Garvan Institute of Medical Research
    Garvan Institute of Medical Research

    Group Lead: Prof. David Thomas

    Garvan's mission is to make significant contributions to medical research that will change the directions of science and medicine and have major impacts on human health. Garvan strives to enhance and develop research programs that combine fundamental science with strong clinical interactions.

    If you would like to make a donation to support breakthrough medical research visit the Garvan's donate page for more information.

    Sub Group:

    Kinghorn Cancer Centre

  • Melanoma Institute Australia
    Melanoma Institute Australia

    Group Leads: Professors Georgina Long and Richard Scolyer

    A non-profit organisation dedicated to preventing and curing melanoma through innovative, world-class research, treatment and education programs.

    Donations to support MIA research can be made by vising this page.


  • Mid North Coast Cancer Institute
    Mid North Coast Cancer Institute

    Group Lead: Tom Shakespeare

    The Mid North Coast Cancer Institute (MNCCI) is a patient centred organisation. It has two world class facilities located at Port Macquarie and Coffs Harbour. Each facility provides an integrated multi-disciplinary team approach to the treatment and support of our patients.

  • Orange Health Service
    Orange Health Service

    Group Lead: Ruth Jones

    A service of the Western NSW Local Health District.


  • Royal Prince Alfred Hospital
    Royal Prince Alfred Hospital

    Group Lead: Assoc. Prof. Philip Beale

    Royal Prince Alfred Hospital is one of Australia's premier tertiary referral hospitals and is recognised as a worldwide leader in healthcare excellence and innovation. RPA is part of a network of hospitals within the  Sydney Local Health District. It is the principal teaching hospital of the University of Sydney.


  • St Vincent's Hospital
    St Vincent's Hospital

    Group Lead: Dr. Anthony Joshua

    Founded in 1857 by the Sisters of Charity, St Vincent's Hospital functions as a full service acute public teaching hospital. Part of the NSW-based arm of St Vincent's Health Australia, the Hospital provides significant training and research activities housing several specialty units that are internationally recognised as centres of excellence.



  • University of Sydney
    University of Sydney

    Group Lead: Prof. John Simes

    Progressive thinking, breaking with convention, challenging the status quo and improving the world around us are in Sydney University's DNA


  • Wagga Wagga Hospital
    Wagga Wagga Hospital

    A part of the Murrumbidgee Local Health District.